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Mycobacterium avium Subspecies
Paratuberculosis (MAP) Matches
qPCR Sensitivity and Reveals
Significant Proportions of Non-viable
MAP in Lymphoid Tissue of
Vaccinated MAP Challenged Animals
Tim J. Bull1*, Tulika Munshi1, Heidi Mikkelsen2, Sofie B. Hartmann2, Maria R. Sørensen2,
Joanna S. Garcia1, Paula M. Lopez-Perez1, Sven Hofmann1, Kai Hilpert1 and
Gregers Jungersen2
1 Institute of Infection and Immunity, St George’s University of London, London, UK, 2 National Veterinary Institute, Technical
University of Denmark (DTU), Kongens Lyngby, Denmark
The quantitative detection of viable pathogen load is an important tool in determining
the degree of infection in animals and contamination of foodstuffs. Current conventional
culture methods are limited in their ability to determine these levels in Mycobacterium
avium subspecies paratuberculosis (MAP) due to slow growth, clumping and low
recoverability issues. The principle goal of this study was to evaluate a novel culturing
process (TiKa) with unique ability to stimulate MAP growth from low sample loads
and dilutions. We demonstrate it was able to stimulate a mean 29-fold increase in
recoverability and an improved sensitivity of up to three logs when compared with
conventional culture. Using TiKa culture, MAP clumping was minimal and produced
visible colonies in half the time required by standard culture methods. Parallel
quantitative evaluation of the TiKa culture approach and qPCR on MAP loads in
tissue and gut mucosal samples from a MAP vaccine-challenge study, showed good
correlations between colony counts (cfu) and qPCR derived genome equivalents (Geq)
over a large range of loads with a 30% greater sensitivity for TiKa culture approach at
low loads (two logs). Furthermore, the relative fold changes in Geq and cfu from the TiKa
culture approach suggests that non-mucosal tissue loads from MAP infected animals
contained a reduced proportion of non-viable MAP (mean 19-fold) which was reduced
significantly further (mean 190-fold) in vaccinated “reactor” calves. This study shows
TiKa culture equates well with qPCR and provides important evidence that accuracy
in estimating viable MAP load using DNA tests alone may vary significantly between
samples of mucosal and lymphatic origin.
Keywords: Mycobacterium avium subspecies paratuberculosis, improved culture, quantification, qPCR, TiKa
culture
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INTRODUCTION
Mycobacterium avium subspecies paratuberculosis (MAP) is
an economically important pathogen (McAloon et al., 2016)
causing Johne’s disease in wide range of wild and domestic
animals that has been linked as a zoonotic agent involved
in the progression of Crohn’s disease in humans (Gitlin
et al., 2012). The ability of MAP to exist in a variety of
phenotypes, some with a high resistance to killing (Grant
and Rowe, 2004), has increased the importance of providing
accurate quantitative estimates of viable counts when testing
for the presence of this pathogen in food (Botsaris et al.,
2016; Galiero et al., 2016; Ricchi et al., 2016), animal
and human samples (Timms et al., 2016). MAP is widely
accepted as a difficult organism to culture reproducibly and
accurately, particularly at low loads (Hines et al., 2007).
This is particularly relevant in early stages of MAP disease
pathogenesis which are often interspersed with periods of low
MAP shedding, presumably as a result of diminutive loads
in tissues (Kalis et al., 2001). MAP culture requires specialist
media supplements, grows only relatively slowly, aggregates
during liquid phases of sample preparation forming various
sized colonies and like other pathogenic mycobacteria is
difficult to recover when plated on solid media in very low
dilution (Harris and Barletta, 2001; Elguezabal et al., 2011).
It is particularly adapted to intracellular persistence and is
known to exhibit several phenotypes (Nazareth et al., 2015).
Whilst detection is not necessarily indicative of clinical disease,
identifying the presence and quantity of viable MAP provides an
important marker of disease and infectious spreading potential,
particularly relevant to optimizing strategies of disease control
at herd level and for individual assessments of treatment
efficacies.
Quantitative detection of viable MAP by culture, particularly
at low loads or from clinical tissue is thus considered
challenging and as a consequence, molecular based detection
systems have been developed (Whittington, 2009). To validate
molecular methods, such as qPCR, however, requires calibration
that assumes accurate colony forming unit or viability count
estimations, efficient DNA extraction and DNA purification
processing (Bull et al., 2003; Elguezabal et al., 2011). Robust
techniques for DNA extraction and purification have provided
means to specifically and reliably detect at least 100–500
genome equivalents (Geq) which when applied to adequate
sample sizes can reduce the sensitivity to single log loads
(Plain et al., 2014). The lack of culture correlation data,
however, has until now prevented accurate means of estimating
the true proportion of viable organisms in any sample
tested.
In this study, we have evaluated a new culture process that
uses supplements able to stimulate MAP growth. We show
that for the first time, this generates sensitive, quantitative and
reliable MAP recovery and culture from infected animals. Using
this as a comparator with molecular methods we demonstrate
that determining MAP presence by DNA based testing alone
can significantly overestimate viable MAP presence in immune-
reactive lymphatic tissue.
MATERIALS AND METHODS
Media and Antibiotics
Middlebrook 7H9/7H11 media and OADC supplement were
obtained from Becton Dickinson, UK, and Mueller Hinton broth
from Merck, USA. All antibiotics were obtained from Apollo
Scientific, UK and chemicals from Sigma, UK unless otherwise
stated. All mycobacterial liquid cultures were set up in BACTEC
MGIT 320 mycobacterial detection system which uses barcoded
tubes with 7 ml media and additional growth supplement (Becton
Dickinson, UK).
Animals, MAP Challenge, and
Vaccinations
Forty-nine Jersey calves (three heifers, 46 bulls) were enrolled in
batches of seven on a Danish Jersey dairy farm with near zero
prevalence of MAP infection as evidenced by several years of
seroprevalence monitoring through the Danish Paratuberculosis
eradication program. Following inoculation, all animals were
housed in community pens with straw bedding in a secluded
area of the farm. As animals reached 6 weeks old, they were
randomly assigned to a single Silirum R© (CZ Veterinaria) (N = 1)
immunization or two immunizations 4 weeks apart with one of
two test vaccines (N = 2 + 2), or a saline sham-vaccination
(N = 2).
All calves were MAP challenged 3 weeks after the last
vaccination which was administered as three consecutive oral
doses. The MAP challenge strain used was a clinical isolate
Ejlskov2007 isolated from the feces of a disease cow cultured
in liquid Middlebrook 7H9 supplemented with 10% OADC,
0.05% Tween 80 and 2 mg/ml Mycobactin J (MB7H9). A pool
of Batch 190115 (7 g pelleted weight) and Batch 100315 (9.7 g
pelleted weight) was thoroughly mixed and re-suspended in
120 ml of MB7H9 media with 15% glycerol before aliquoting
into 5 ml vials (each containing 0.7 g pelleted MAP weight).
To best estimate the number of MAP Geq per aliquot we
used a qPCR directed against a single copy MAP gene (FadE5)
using primer pairs (5′-AAGTCGAACAGGAACTTGGG-3′, 5′-
TCGAGAACATCTTCCACCTG-3′) that had been previously
shown to give accurate evaluations at the concentrations
expected. All samples were run in duplicate using 2.5 µl DNA
(5× pre-diluted) template, 12.5 µl QuantiTect SYBR green
PCR kit (Qiagen, UK) and 0.125 µl of each primer (10 µM
stock) in a total volume of 25 µl using a Rotor-Gene Q
(Qiagen, UK) PCR machine. PCR cycling included an initial
denaturation at 95◦C for 15 min, followed by 45 cycles of
95◦C: 30 s, 62◦C : 60 s. Data analysis was performed using
the Rotor-Gene Q Series Software version 1.7. All aliquots
were then frozen at −80◦C. One to three days prior to each
block-inoculation, a vial was thawed, added to 15 ml sterile
PBS, blended with single use sterile plastic homogenizer to
resolve MAP clumps and refrigerated until use. On the morning
of inoculation the material was re-suspended and aliquoted
in 2 ml subsamples each containing 100 mg MAP. At the
time of inoculation each tube was re-suspended in 800 ml
warmed (37◦C) fresh milk and fed individually by calf drench.
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A total of three inoculations were given to each calf every
second day. All calves were fed milk daily up to the time of
inoculation to maintain the gastro-oesophageal reflex bypassing
the rumen.
Sample Testing
At 28 weeks post challenge, all animals were euthanized and
necropsied. Approximately 8 cm intestinal tissue was collected
from ileal and jejunal sites of each animal located at various
distances 0, 25, 50, 150, and 250 cm from the ileocecal
valve in the proximal direction. All samples included Peyer’s
patches were processed within 2 days of slaughter without prior
freezing. DNA extraction method was as previous described
(Park et al., 2014) with some modification. Samples of 100 mg
tissue in 1.5 Milli-Q water were refrigerated 16–40 h and
centrifuged at 15,000 × g for 15 min at room temperature
(RT) and the tissue pellet re-suspended in 360 µl Qiagen
tissue lysis (ATL) buffer and 40 µl proteinase K (Qiagen,
UK) vortexed and incubated while shaking at 56◦C for 1 h.
Samples were again centrifuged 15,000 × g for 15 min (RT)
and the supernatant discarded. Pellets were re-suspended in
275 µl enzymatic lysis buffer for gram-positive bacteria [20 mM
TrisHCL (pH 8.0), 2 mM sodium EDTA, 1.2% Triton X-100,
and 20 mg/ml lysozyme] and 200 µl 0.1 mm Zirconia/Silica
beads (Biospec Products, Inc., USA) were added followed by
incubation while shaking at 37◦C for 30 min. This was followed
by beat beating, 45 s at 30 rpm, using a TissueLyzer II
(Retsch, Germany). To reduce foaming, samples were spun
down for 30 s at 15,000 × g. Then 25 µl proteinase-K
and 300 µl Qiagen DNeasy lysis (AL) buffer was added and
incubated with gentle shaking at 56◦C for 2 h followed by
bead beating for 45 s at full speed (30 rpm) and centrifugation
at 12,000 × g for 10 min. The supernatant was transferred
to a new reaction tube without beads and 100% ethanol
added at the ratio of 1 to 2 (ethanol:supernatant). DNA
extraction procedure followed the Spin-Column protocol from
the Qiagen DNeasy Blood and Tissue kit (Qiagen, UK). DNA
was eluted in 50 µl AE buffer and frozen at −20◦C. All samples
were diluted five times and then only 1/10 of each sample
was assayed to avoid PCR inhibition due to possible DNA
overload.
Quantitative PCR was performed using an in house system
(Thakur, 2012) validated against a MAP DNA/spiked tissue
DNA calibration curve using reactions targeting IS900 with the
validated primer set 5′-GGCAAGACCGACGCCAAAGA-3′, 5′-
GGGTCCGATCAGCCACCAGA-3′. IS900 was used in prefe-
rence to FadE5 due to its presence in multiple copies that ensure
increased sensitivity and robustness of testing low loads. All
samples were run in duplicate as above with denaturation at
95◦C, followed by 45 cycles of 95◦C: 30 s, 68◦C: 60 s. Data analysis
was performed using the Rotor-Gene Q Series Software version
1.7 using a calibration set of DNA dilutions from a standard MAP
DNA stock included in all runs (efficiency: 89%, R2: 0.99780). The
lower detection limit was determined according to a standard
Cq of 33.57 representing a previously estimated sensitivity of
approximately 1.7 Geq. Acceptable duplicate variation was set at
1.5 Cq.
Culture
Hexadecylpyridinium chloride (HPC: Sigma, UK) sample
decontamination was carried out according to World
Organisation for Animal Health (OIE) standard protocols
(Edwards, 2007). Briefly, 100 mg of homogenized sample was
added to 1.5 ml sterile 0.75% HPC and incubated at 37◦C for 3 h.
Samples were centrifuged at 1,600 × g for 30 min, supernatant
discarded, the pellet resuspended in 0.5 ml of 1/2 strength Muller
Hinton (1/2MH) Broth with 100 µg/ml Vancomycin, 50 µg/ml
Amphotericin B, 100 µg/ml Nalidixic acid and incubated
overnight at 37◦C with gentle shaking. Tubes were allowed to
settle for 30 min and 100 µl inoculum taken from the middle of
the suspension.
TiKa-Kic sample decontamination used 100 mg of
homogenized sample digested for 5 h at 37◦C with gentle
shaking (200 rpm) in 1 ml CT digest buffer [8.5 mg/ml NaCl,
1 mg/ml CaCl2, 100 mg/ml Collagenase B (Roche, UK), and
100 mg/ml Trypsin]. Digests were centrifuged at 14,000 × g
for 10 min and the supernatant discarded. The pellet was then
re-suspended in 10 ml 1/2MH broth supplemented with TiKa-Kic
(TiKa Diagnostics, UK) and incubated for 24 h at 37◦C with
gentle shaking. Samples were centrifuged 1,600 × g for 30 min
and the pellet re-suspended in 600 µl sterile PBS.
TiKa14D-7H11 solid culture used Middlebrook 7H11, 10%
OADC, 2 mg/ml Mycobactin J (ID-Vet, France), 25 µg/ml
Vancomycin, 30 µg/ml Amphotericin B, 25 µg/ml Nalidixic
acid, 1 µg/ml TiKa-14D and was inoculated with effectively 1/6
(100µl) of each treated sample. All plates were read from 3 weeks
and cfu’s confirmed at 10 weeks.
TiKa-MGIT liquid culture used 7 ml MGIT tubes with
0.8 ml growth supplement, 2 mg/ml Mycobactin J (ID-Vet,
France), 25 µg/ml Vancomycin, 30 µg/ml Amphotericin B,
25 µg/ml Nalidixic acid, 1 µg/ml TiKa-14D and were inoculated
with 5/6 (500 µl) of each treated sample. Sample loads were
calculated by extrapolation using a calibration algorithm from
Time to Positivity (TTP measured in days) of each MGIT tube
when flagged positive by the Bactec MGIT 320 mycobacterial
detection system as determined by the manufacturer. The
calibration algorithm cfl/g tissue = (3 × 106)(−0.347 × TTP days)
was determined from a previous spiking experiments of known
dilutions of MAP (strain K10) grown in TiKa14D+MGIT media
(data not shown). Processing by qPCR for IS900 was performed
in a separate research facility to culture and all results and
identities of animal groups were kept blinded until the end of the
experiment.
Samples from various tissue sites obtained from each
animal at necropsy were processed in parallel to compare
standard and TiKa-Kic methods. They were then quantitatively
tested in parallel for the presence of either MAP Geq by
qPCR, colony forming units (cfu) using TiKa14D + 7H11
colony counting or extrapolated colony forming load (cfl)
by determining initial inoculum load from TTPdays results
of TiKa14D + MGIT liquid culture. Samples from one cull
set were additionally tested by MAP culture on unmodified
7H11 plates after preparation using a conventional HPC based
method (cfu, HPC). Mean individual total counts for each
of the methods (cfu/cfl/Geq) were determined by summing
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the estimated load from each of the 10 samples from each
animal.
Statistical Analysis
All statistical analyses were performed using Graph Pad Prism
v6.01. For all analyses, a p-value of <0.05 was considered
to be statistically significant. The criteria for interpreting
the Spearman’s rank correlation with p-value <0.001 was
>0.75 = excellent, <0.40 = poor, 0.40–0.75 = good (Fleiss et al.,
2003).
RESULTS
Seven blocks of seven calves (n = 49) were purchased at 6 weeks
of age and randomly assigned to vaccine or sham-vaccinated
groups. Results of individual vaccine efficacy will be reported
elsewhere. Two animals were euthanized as a result of causes
unrelated to the experiment (one broken leg, one malformed
pyloric sphincter) and were excluded. The remainder, comprising
34 vaccinated and 13 sham-vaccinated (Saline) individuals were
successfully challenged 3 weeks post vaccination with an oral dose
of MAP (total inoculum estimated by qPCR : 1 × 1013 Geq) and
maintained in appropriate housing for 28 weeks post challenge.
Final MAP loads adjusted for sample weight and collated as cfu,
cfl, or Geq per 100 mg of sample tissue (Supplementary Table S1)
showed all animals had at least 70% of samples positive for MAP
by at least one method with 3% (16/470) being negative by all
three methods. Sample contamination due to direct carry over of
viable non-mycobacterial flora was seen in only one of 470 sample
preparations using the TiKa-Kic with TiKa14D + MGIT liquid
culture. No carry over contamination was seen using HPC with
7H11 or TiKa-Kic with TiKa14D+ 7H11 culture.
Comparing total load estimates of individual vaccinated
animals with the sham-vaccinated (saline) control group we
were able to identify a subgroup (designated as “reactor” group)
within the vaccinated animal group that had total load means
significantly (cfu: p = <0.0001; cfl: p = <0.0002; and Geq:
p= 0.042) below that of controls by all three methods (Figure 1).
The conventional HPC + 7H11 solid method performed
the poorest relative to all other methods. Cultures showed an
apparently random proportion of large colonies indicative of
clumping present in all HPC positive cultures and required a
significantly longer period (TiKa-Kic with TiKa14D + 7H11
culture 3–4 weeks, HPC 8–10 weeks) to generate visible colonies.
Contrastingly, nearly all colonies grown using TiKa-Kic with
TiKa14D+ 7H11 culture were of a regular size and not suggestive
of growing from clumps. There was good correlation of load
estimates (r = 0.810, p=<0.0001) between Geq from qPCR and
cfu from HPC at high sample loads (Figure 2A) but this was
shifted from a 1:1 relationship by a mean 189-fold (median 72-
fold) difference. In addition the sensitivity of detection (negative
cut off) for HPC treated sampling was relatively low with 37%
(12/30) positive qPCR values showing no cfu on HPC with 7H11
solid medium even after 12 weeks incubation. In this small
sample comparison the TiKa-Kic with TiKa14D+ 7H11 protocol
was markedly superior to HPC with conventional 7H11 solid
FIGURE 1 | Distribution plots of total Mycobacterium avium
subspecies Paratuberculosis (MAP) loads in different methods. Plots
derived by summing loads from 10 samples for each animal determined from
the same set of samples (n = 470) by three separate methods (A) cfu using
TiKa-Kic/Tika14D + 7H11 method (p = <0.0001), (B) cfu using
TiKa-Kic/Tika14D + MGIT method (p = <0.0002) and (C) Geq using qPCR
(p = <0.042) on control and vaccinated groups of calves. There was no
statistical significance between saline and non-reactor groups in all methods.
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FIGURE 2 | Correlation plots of MAP loads in individual samples from
mucosal and non-mucosal tissues. These plots were estimated by three
methods (A) cfu by hexadecylpyridinium chloride (HPC) with qPCR at median
72-fold, mean 189-fold, and Spearman r at 0.810; (B) cfu by HPC with cfu by
TiKa-Kic/Tika14D + 7H11 at median eightfold, mean 29-fold, and Spearman r
at 0.723 and (C) cfu by TiKa-Kic/Tika14D + MGIT with qPCR at median
1.6-fold, mean 13-fold, and Spearman r at 0.963 for mucosal samples and at
median eightfold, mean 117-fold, and Spearman r at 0.845 for non-mucosal
samples (qPCR = Geq). Dotted lines represent medians.
medium. TiKa-Kic with TiKa14D + 7H11 culture provided a
mean 29-fold (median eightfold) increase in cfu values relative
to HPC with 7H11 culture (Figure 2B) and markedly improved
recovery with MAP being grown from all HPC negatives (range
7–6,129 cfu/100 mg).
TiKa solid culture showed excellent correlation with qPCR,
particularly in mucosal samples (r = 0.963, p = <0.0001) that
approached a linear relationship (mean 13-fold, median 1.6-fold
differences in count loads). When these data were separated
into populations of mucosal and tissue samples the correlation
remained excellent but reduced (r = 0.845, p = <0.0001) with
fold differences in count loads shifting proportionally toward
Geq (mean 117-fold, median eightfold), suggesting variations
influencing cfu values could be tissue specific (Figure 2C).
Extension of this analysis correlating qPCR Geq values and
TiKa-Kic with TiKa14D + 7H11 cfu across all tested animals
confirmed this observation (Figure 3). Correlation of Geq and
cfu using TiKa-Kic with TiKa14D + 7H11 across all (n = 282)
animal mucosal samples (Figure 3A) was good (r = 0.723,
p = <0.0001) with a close linear relationship over a wide
range of values (mean twofold, median onefold). A significant
shift was again observed in mean differences between Geq
and cfu in non-mucosal tissue samples with mean 19-fold
(median eightfold) for controls that increased significantly to
232-fold (median 57-fold) if the vaccine “reactor” group was
considered separately (Figure 3B). In this experiment, TiKa-
Kic with TiKa14D + 7H11 culture was more sensitive than
qPCR with 28% (79/282) samples cfu positive/qPCR Geq negative
(range 2–156 cfu/100 mg tissue). In contrast only 1% (3/282)
of mucosal samples were cfu negative/PCR Geq positive (range
36–209 Geq/100 mg tissue).
Correlations with qPCR and TiKa-Kic with TiKa14D+MGIT
liquid culture had similar outcomes with near linear correlations
in mucosal samples (Supplementary Figure S1) and a significant
shift in mean differences of 107-fold (median 53-fold) in “reactor”
animals relative to qPCR. TiKa-Kic with TiKa14D + MGIT
liquid culture was also more sensitive than qPCR with 28%
(79/282) samples cfl positive/qPCR Geq negative (range 2–
156 cfl/100 mg tissue) and only 1% (3/282) of mucosal samples
were cfl negative/qPCR Geq positive (range 36–209 Geq/100 mg
tissue).
DISCUSSION
The slow nature of MAP growth and its consequent sample
turnaround time with conventional culture has promoted the
development of highly sensitive molecular methods as an
attractive rapid alternative. However, molecular quantification
of Geq as a measure does not provide any indication of load
viability. Previous comparative studies of qPCR and conventional
culture have demonstrated good correlation in high sample
loads present in feces (Douarre et al., 2010; Mita et al., 2016)
but the inability of conventional culture methods to accurately
culture low loads of viable organisms from clinical samples
introduces problems. Culture sensitivity for MAP has only
ever been as good as 2–3 log10 (Ricchi et al., 2016), thus at
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FIGURE 3 | Correlation plots of MAP loads comparing TiKa14D + 7H11
and qPCR. Individual samples estimated as cfu by TiKa-Kic/Tika14D + 7H11
and Geq by qPCR for (A) mucosal having control (median onefold and mean
twofold), vaccinated non-reactor (median twofold and mean twofold) and
vaccinated reactor (median fourfold and mean 13-fold) groups of calves and
(B) non-mucosal tissues also having control (median eightfold and mean
19-fold), vaccinated non-reactor (median eightfold and mean 29-fold) and
vaccinated reactor (median 60-fold and mean 190-fold) groups of calves.
Dotted lines represent medians. Spearman r for each was 0.723 and 0.717,
respectively.
low loads correlations to DNA presence are difficult to obtain
and the true relationship between genome equivalent values
and the demonstrable viable MAP count in these samples
remains uncertain (Kralik et al., 2012; Plain et al., 2015).
The underlying reasons for these discrepancies are probably
multi-variant. DNA detection from difficult samples such as
feces are often significantly influenced by carry-through of
amplification enzyme inhibitors and the necessity for multiple
steps in sample processing that can introduce error (Timms
et al., 2015). Furthermore, the need to decontaminate samples of
commensal bacterial and fungal flora introduces MAP exposure
during sample preparation to chemicals and antibiotics that
can inhibit and in some cases kill large proportions of the
viable load (Gumber and Whittington, 2007; Kralik et al.,
2014). These variables make it difficult to define the number
of samples and quantity of any one sample which should be
tested to gain significant confidence when assessing true test
negativity.
In this study, we have used samples available from a
vaccine-challenge experiment to evaluate the Tika culture system
which uses a novel sample preparation protocol (TiKa-Kic) and
supplemented growth media (TiKa + 7H11, TiKa + MGIT).
The sample preparation method differs from conventional
protocols in not requiring harsh chemical treatment of samples
such as HPC, sodium hydroxide and oxalic acid to remove
contaminating flora. The TiKa-Kic killing cocktail has no
influence on mycobacterial growth or viability but is effective
against a wide range of other bacterial and fungal genera. When
followed by growth in conventional MAP media (either liquid
or solid) supplemented with a growth enhancer (TiKa14D)
there is stimulation of MAP growth and suppression of both
MAP aggregation/clumping and entry into lag phase. Parallel
processing of samples from experimentally challenged calves
comparing TiKa with a standard HPC sample protocol showed
a mean 184-fold greater growth of MAP load with colonies
appearing 3–4 weeks before the majority of colonies detected
using HPC treated samples. In addition 30% of qPCR positive
processed samples when processed with conventional HPC
treatment, produced no visible recovery after 8–10 weeks
incubation whilst TiKa-Kic treatment allowed growth of regular
sized colonies in each of these samples.
Parallel processing of mucosal tissue samples from
experimentally infected calves showed that TiKa culture
gave excellent correlations at medium and high MAP loads
with genome equivalent (Geq) estimates derived using a qPCR
with a dynamic range cut off of 1.7 Geq. A major finding of
this study showed that TiKa culture was the most sensitive test
with 22% of cfu positive TiKa treated samples from control
animals being negative in qPCR (mean = 455 cfu : range
14–1,564 cfu). This difference could be explained to some extent
by the specific sample volume used for qPCR which was required
to be 20-fold less than for TiKa sampling to ensure avoidance
of carry over inhibitors. These results suggest TiKa culture was
able to consistently recover and grow colonies from a significant
majority of the MAP load within mucosal tissue and that this
represents a 2 log10 improvement over any existing culture
protocol. Subsequent testing using this qPCR method should
consider raising the sample volume if possible.
Further analysis of the data was able to discern that fold
differences between MAP genome equivalent loads (qPCR)
and MAP viable loads (cfu) in lymph node tissues was
significantly and consistently different to that of mucosal samples.
Correlations of cfu and Geq values from MAP infected control
animals remained linear but produced a mean 19-fold (median
eightfold) decrease in culturable MAP load of lymphatic tissue
compared to mucosal tissue. There was no evidence of increases
in clumping in these samples and the correlation appeared good
over the whole range of loads suggesting that this was not a
technical phenomenon. Similar shifts were observed in both solid
and liquid TiKa supplemented media. We surmise that lymphatic
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tissue was evoking a significant effect on the viability of this
proportion of MAP in all animals regardless of vaccination status.
Importantly this was not the case in mucosal tissue suggesting
that this effect was tissue specific. Interestingly, a sub group
of the animals (referred to here as “reactors”) that had been
MAP-vaccinated prior to MAP challenge and had responded
by decreasing the MAP load in both mucosal and lymphatic
tissue significantly below any of the sham-vaccinated controls
showed the largest effect in this regard. Vaccine “reactors” had
a mean 100-fold greater reduction in fold differences between
Geq and cfu than seen in mucosal tissue from the same
animals and 10-fold greater reduction than equivalent tissue
from sham-vaccinated controls. This data suggests that at the
selected time point (7 months post challenge) MAP vaccine
“reactors” were harboring up to 3 log10 greater proportion
of dead or possibly non-culturable/viable “dormant” MAP in
their lymphatic tissue. Why this population should be absent
from mucosal tissue requires more directed studies including
detailing the predominant metabolic state and degree of viability
of MAP in active lymphatic tissue. We hypothesize that vaccine
“reactors” are generating more active MAP killing mechanisms
and the increased residual DNA presence in lymphatic tissue is a
result of the detection of killed MAP which unlike the mucosal
compartment have not yet been fully processed and translocated
for excretion.
CONCLUSION
TiKa culture provides the most efficient and rapid method of
culturing MAP so far described. It validates the use of qPCR
for rapid determination of viable MAP load in mucosal tissue
and when applied together with qPCR could offer the possibility
of a novel method to monitor vaccine efficacy. Importantly this
study shows that qPCR is not an accurate method of quantifying
viable MAP load in lymphatic tissue as this varies widely within
individuals with diverse immunologically reactive status. Future
studies are required to evaluate the utility of TiKa culture
and determine the true proportion of MAP viability in these
samples.
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FIGURE S1 | Correlation plots of MAP loads comparing TiKa-MGIT and
qPCR. Individual samples estimated as cfu by TiKa-Kic/Tika14D + MGIT and
Geq by qPCR for (A) mucosal having control (median onefold, mean onefold),
vaccinated non-reactor (median onefold, mean twofold) and vaccinated reactor
(median onefold, mean fivefold) groups of calves and (B) non-mucosal tissues also
having control (median 30-fold, mean 61-fold), vaccinated non-reactor (median
21-fold, mean 39-fold) and vaccinated reactor (median 53-fold, mean 107-fold)
groups of calves. Dotted lines represent medians. Spearman r for each was 0.744
and 0.681 respectively.
TABLE S1 | Results of observed cfu and calculated cfl, Geq obtained from
each individual sample. For clarity results are tabulated into three categories
(Vaccinated ‘Reactors’, Vaccinated ‘Non-Reactors’ and Sham vaccinated
Controls). Each sample code uses the format; animal number – tissue site
(I = Ileum, J = Jejunum, IV = Ileocecal Valve, LN = Lymph node) – distance of
sampling site along Ileum or Jejunum. Median and Mean values of each protocol
are tabulated under the ‘Reactor’ group columns.
REFERENCES
Botsaris, G., Swift, B. M., Slana, I., Liapi, M., Christodoulou, M., Hatzitofi, M., et al.
(2016). Detection of viable Mycobacterium avium subspecies paratuberculosis
in powdered infant formula by phage-PCR and confirmed by culture.
Int. J. Food Microbiol. 216, 91–94. doi: 10.1016/j.ijfoodmicro.2015.
09.011
Bull, T. J., McMinn, E. J., Sidi-Boumedine, K., Skull, A., Durkin, D.,
Neild, P., et al. (2003). Detection and verification of Mycobacterium avium
subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from
individuals with and without Crohn’s disease. J. Clin. Microbiol. 41, 2915–2923.
doi: 10.1128/JCM.41.7.2915-2923.2003
Douarre, P. E., Cashman, W., Buckley, J., Coffey, A., and O’Mahony, J. M. (2010).
Isolation and detection of Mycobacterium avium subsp. paratuberculosis
(MAP) from cattle in Ireland using both traditional culture and molecular based
methods. Gut Pathog. 2, 11. doi: 10.1186/1757-4749-2-11
Edwards, S. (2007). OIE standards for vaccines and future trends. Rev. Sci. Tech.
26, 373–378.
Elguezabal, N., Bastida, F., Sevilla, I. A., Gonzalez, N., Molina, E., Garrido, J. M.,
et al. (2011). Estimation of Mycobacterium avium subsp. paratuberculosis
growth parameters: strain characterization and comparison of methods. Appl.
Environ. Microbiol. 77, 8615–8624. doi: 10.1128/AEM.05818-11
Fleiss, J. L., Levin, B. A., and Paik, M. C. (2003). Statistical Methods for Rates and
Proportions. Hoboken, NJ: John Wiley & Sons.
Galiero, A., Fratini, F., Mataragka, A., Turchi, B., Nuvoloni, R., Ikonomopoulos, J.,
et al. (2016). Detection of Mycobacterium avium subsp. paratuberculosis in
cheeses from small ruminants in Tuscany. Int. J. Food Microbiol. 217, 195–199.
doi: 10.1016/j.ijfoodmicro.2015.10.029
Gitlin, L., Borody, T. J., Chamberlin, W., and Campbell, J. (2012).
Mycobacterium avium ss paratuberculosis-associated Diseases: Piecing
the Crohn’s Puzzle Together. J. Clin. Gastroenterol. 46, 649–655.
doi: 10.1097/MCG.0b013e31825f2bce
Grant, I. R., and Rowe, M. T. (2004). Effect of chemical decontamination
and refrigerated storage on the isolation of Mycobacterium avium subsp.
paratuberculosis from heat-treated milk. Lett. Appl. Microbiol. 38, 283–288.
doi: 10.1111/j.1472-765X.2004.01498.x
Frontiers in Microbiology | www.frontiersin.org 7 January 2017 | Volume 7 | Article 2112
fmicb-07-02112 December 26, 2016 Time: 15:5 # 8
Bull et al. Improved Culture Medium for MAP
Gumber, S., and Whittington, R. J. (2007). Comparison of BACTEC 460 and MGIT
960 systems for the culture of Mycobacterium avium subsp. paratuberculosis S
strain and observations on the effect of inclusion of ampicillin in culture media
to reduce contamination.Vet.Microbiol. 119, 42–52. doi: 10.1016/j.vetmic.2006.
08.009
Harris, N. B., and Barletta, R. G. (2001). Mycobacterium avium subsp.
paratuberculosis in Veterinary medicine. Clin. Microbiol. Rev. 14, 489–512.
doi: 10.1128/CMR.14.3.489-512.2001
Hines, M. E. II, Stabel, J. R., Sweeney, R. W., Griffin, F., Talaat, A. M., Bakker, D.,
et al. (2007). Experimental challenge models for Johne’s disease: a review and
proposed international guidelines. Vet. Microbiol. 122, 197–222. doi: 10.1016/j.
vetmic.2007.03.009
Kalis, C. H., Hesselink, J. W., Barkema, H. W., and Collins, M. T. (2001). Use
of long-term vaccination with a killed vaccine to prevent fecal shedding of
Mycobacterium avium subsp paratuberculosis in dairy herds. Am. J. Vet. Res.
62, 270–274. doi: 10.2460/ajvr.2001.62.270
Kralik, P., Babak, V., and Dziedzinska, R. (2014). Repeated cycles of chemical
and physical disinfection and their influence on Mycobacterium avium
subsp. paratuberculosis viability measured by propidium monoazide F57
quantitative real time PCR. Vet. J. 201, 359–364. doi: 10.1016/j.tvjl.2014.
05.032
Kralik, P., Beran, V., and Pavlik, I. (2012). Enumeration of Mycobacterium avium
subsp. paratuberculosis by quantitative real-time PCR, culture on solid media
and optical densitometry. BMC Res. Notes 5:114. doi: 10.1186/1756-0500-
5-114
McAloon, C. G., Whyte, P., More, S. J., Green, M. J., O’Grady, L., Garcia, A., et al.
(2016). The effect of paratuberculosis on milk yield–A systematic review and
meta-analysis. J. Dairy Sci. 99, 1449–1460. doi: 10.3168/jds.2015-10156
Mita, A., Mori, Y., Nakagawa, T., Tasaki, T., Utiyama, K., and Mori, H. (2016).
Comparison of fecal pooling methods and DNA extraction kits for the detection
of Mycobacterium avium subspecies paratuberculosis. Microbiologyopen 5, 134–
142. doi: 10.1002/mbo3.318
Nazareth, N., Magro, F., Appelberg, R., Silva, J., Gracio, D., Coelho, R., et al.
(2015). Increased viability but decreased culturability of Mycobacterium avium
subsp. paratuberculosis in macrophages from inflammatory bowel disease
patients under Infliximab treatment. Med. Microbiol. Immunol. 204, 647–656.
doi: 10.1007/s00430-015-0393-2
Park, K. T., Allen, A. J., and Davis, W. C. (2014). Development of a novel
DNA extraction method for identification and quantification of Mycobacterium
avium subsp. paratuberculosis from tissue samples by real-time PCR.
J. Microbiol. Methods 99, 58–65. doi: 10.1016/j.mimet.2014.02.003
Plain, K. M., Marsh, I. B., Waldron, A. M., Galea, F., Whittington, A. M., Saunders,
V. F., et al. (2014). High-throughput direct fecal PCR assay for detection
of Mycobacterium avium subsp. paratuberculosis in sheep and cattle. J. Clin.
Microbiol. 52, 745–757. doi: 10.1128/JCM.03233-13
Plain, K. M., Waldron, A. M., Begg, D. J., de Silva, K., Purdie, A. C.,
and Whittington, R. J. (2015). Efficient, validated method for detection of
mycobacterial growth in liquid culture media by use of bead beating, magnetic-
particle-based nucleic acid isolation, and quantitative PCR. J. Clin. Microbiol.
53, 1121–1128. doi: 10.1128/JCM.03521-14
Ricchi, M., Savi, R., Bolzoni, L., Pongolini, S., Grant, I. R., De Cicco, C., et al.
(2016). Estimation of Mycobacterium avium subsp. paratuberculosis load in raw
bulk tank milk in Emilia-Romagna Region (Italy) by qPCR. Microbiologyopen
5, 551–559. doi: 10.1002/mbo3.350
Thakur, A. (2012). Development of a Multi-Stage Vaccine Against Paratuberculosis
in Cattle. PhD, thesis. Technical University of Denmark, Copenhagen.
Timms, V. J., Daskalopoulos, G., Mitchell, H. M., and Neilan, B. A. (2016).
The Association of Mycobacterium avium subsp. paratuberculosis with
Inflammatory Bowel disease. PLoS ONE 11:e0148731. doi: 10.1371/journal.
pone.0148731
Timms, V. J., Mitchell, H. M., and Neilan, B. A. (2015). Optimisation of DNA
extraction and validation of PCR assays to detect Mycobacterium avium subsp.
paratuberculosis. J. Microbiol. Methods 112, 99–103. doi: 10.1016/j.mimet.2015.
03.016
Whittington, R. J. (2009). Factors affecting isolation and identification of
Mycobacterium avium subsp. paratuberculosis from fecal and tissue samples
in a liquid culture system. J. Clin. Microbiol. 47, 614–622. doi: 10.1128/JCM.
01986-08
Conflict of Interest Statement: TB and KH Hilpert declare their affiliation with
TiKa Diagnostics Ltd. The company did not influence the design, conduction,
interpretation, or evaluation of this study. All the other authors declare that the
research was conducted in the absence of any commercial or financial relationships
that could be construed as a potential conflict of interest.
Copyright © 2017 Bull, Munshi, Mikkelsen, Hartmann, Sørensen, Garcia, Lopez-
Perez, Hofmann, Hilpert and Jungersen. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 8 January 2017 | Volume 7 | Article 2112
